Design Therapeutics, Inc.

Historical 13F Holders

Symbol
DSGN
CUSIP
25056L103
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 25056L103 since 12/18/2024, largest first.

Filer % of Class Filed
SR One Capital Fund I Aggregator LP 13D/A
10.7% 3/11/2026
Event 3/9/2026
Sirenia Capital Management LP 13G
9.5% 8/14/2026
Event 6/30/2026
Light Irrevocable Trust #1 dated April 22, 2019 13G/A
6.9% 2/7/2025
Event 12/31/2024
Star Irrevocable Trust #1 dated April 22, 2019 13G/A
6.9% 2/7/2025
Event 12/31/2024
Driehaus Capital Management LLC 13G 5.8% 11/16/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Logos Global Management LP 13D/A
4.4% 11/18/2025
Event 11/14/2025
Point72 Asset Management, L.P. 13G/A
3.8% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 142 53.3 M $670M
2026 Q2 137 51.0 M $737M
2026 Q1 126 45.7 M $486M
2025 Q4 119 45.8 M $430M
2025 Q3 95 34.5 M $260M
2025 Q2 94 34.5 M $116M
2025 Q1 99 34.5 M $133M
2024 Q4 96 33.5 M $206M
2024 Q3 102 32.0 M $172M
2024 Q2 97 32.1 M $108M
2024 Q1 94 30.7 M $124M
2023 Q4 89 31.7 M $84.0M
2023 Q3 88 32.9 M $77.6M
2023 Q2 98 38.8 M $244M
2023 Q1 100 38.7 M $223M
2022 Q4 86 40.4 M $414M
2022 Q3 81 39.9 M $667M
2022 Q2 75 38.7 M $542M
2022 Q1 64 38.0 M $614M
2021 Q4 61 36.2 M $773M
2021 Q3 53 28.3 M $415M
2021 Q2 51 27.8 M $546M
2021 Q1 44 25.8 M $755M